Predictors of Patient Activation among Individuals with Multiple Sclerosis: Evidence from a Cross-Sectional Study

Authors

  • Ali Mahdi Mohammed Department of Clinical Pharmacy, College of Pharmacy, University of Baghdad, Baghdad, Iraq; Al Rusafa Health Directorate, Baghdad, Iraq https://orcid.org/0009-0004-7775-3905
  • Samer Imad Mohammed Department of Clinical Pharmacy, College of Pharmacy, University of Baghdad, Baghdad, Iraq https://orcid.org/0000-0001-7073-9976
  • Zuhair Abdul-Ghafoor Al-Johar Department of Medicine, College of Medicine, University of Baghdad, Baghdad, Iraq https://orcid.org/0000-0001-7533-0184

DOI:

https://doi.org/10.54133/ajms.v10i2.2901

Keywords:

Cross-sectional study, Multiple sclerosis , Patient activation , PAM-13, Self-management

Abstract

Background: Multiple sclerosis (MS) is a chronic neurological disease that requires long-term self-management and active patient engagement. Patient activation reflects an individual’s knowledge, confidence, and skills to manage their health, yet evidence in MS populations, particularly in low- and middle-income countries, remains limited. Objective: To determine the level of patient activation in people with MS and investigate its connection with demographic and clinical characteristics. Methods: This is a cross-sectional study carried out on 100 individuals diagnosed with MS and admitted to a specialized MS center of Baghdad Teaching Hospital. The Patient Activation Measure (PAM-13) was used to measure patient activation. The demographic and clinical factors were represented by age, gender, educational attainment, marital status, residential status, and level of disability assessed by the Expanded Disability Status Scale (EDSS). Results: The average age of the participants was 33.98±10.4 years, with an average PAM-13 score of 77.18±3.83. The majority (98%) of the participants fell to the highest level of activation (level 4). Patient activation did not have any significant association with demographic or clinical variables. Conclusions: Patients with MS were highly patient activated, which means that they were very active in the self-management of the disease.

Downloads

Download data is not yet available.

References

Compston A, Coles A. Multiple sclerosis. Lancet. 2008;372(9648):1502-1517. doi: 10.1016/S0140-6736(08)61620-7.

Walton C, King R, Rechtman L, Kaye W, Leray E, Marrie RA, et al. Rising prevalence of multiple sclerosis worldwide: Insights from the Atlas of MS, third edition. Mult Scler. 2020;26(14):1816. doi: 10.1177/1352458520970841.

Filippi M, Bar-Or A, Piehl F, Preziosa P, Solari A, Vukusic S, et al. Multiple sclerosis. Nat Rev Dis Primers. 2018;4(1). doi: 10.1038/S41572-018-0041-4.

Amato MP, Zipoli V, Portaccio E. Cognitive changes in multiple sclerosis. Expert Rev Neurother. 2008;8(10):1585-1596. doi: 10.1586/14737175.8.10.1585.

Boeije HR, Duijnstee MSH, Grypdonck MHF, Pool A. Encountering the downward phase: Biographical work in people with multiple sclerosis living at home. Soc Sci Med. 2002;55(6):881-893. doi: 10.1016/S0277-9536(01)00238-6.

Lorig KR, Holman HR. Self-management education: history, definition, outcomes, and mechanisms. Ann Behav Med. 2003;26(1):1-7. doi: 10.1207/S15324796ABM2601_01.

Hibbard JH, Stockard J, Mahoney ER, Tusler M. Development of the patient activation measure (PAM): conceptualizing and measuring activation in patients and consumers. Health Serv Res.

2004;39(4 Pt 1):1005-1026. doi: 10.1111/J.1475-6773.2004.00269.X.

Hibbard JH, Greene J. What the evidence shows about patient activation: better health outcomes and care experiences; fewer data on costs. Health Aff (Millwood). 2013;32(2):207-214. doi: 10.1377/HLTHAFF.2012.1061.

Begum N, Donald M, Ozolins IZ, Dower J. Hospital admissions, emergency department utilisation and patient activation for self-management among people with diabetes. Diabetes Res Clin Pract. 2011;93(2):260-267. doi: 10.1016/J.DIABRES.2011.05.031.

Greene J, Hibbard JH. Why does patient activation matter? An examination of the relationships between patient activation and health-related outcomes. J Gen Intern Med. 2012;27(5):520-526. doi: 10.1007/S11606-011-1931-2.

Skolasky RL, Green AF, Scharfstein D, Boult C, Reider L, Wegener ST. Psychometric properties of the patient activation measure among multimorbid older adults. Health Serv Res. 2011;46(2):457-478. doi: 10.1111/J.1475-6773.2010.01210.X.

Stepleman L, Rutter MC, Hibbard J, Johns L, Wright D, Hughes M. Validation of the patient activation measure in a multiple sclerosis clinic sample and implications for care. Disabil Rehabil. 2010;32(19):1558-1567. doi: 10.3109/09638280903567885.

Marrie RA, Horwitz R, Cutter G, Tyry T, Campagnolo D, Vollmer T. High frequency of adverse health behaviors in multiple sclerosis. Mult Scler. 2009;15(1):105-113. doi: 10.1177/1352458508096680.

Benedict RHB, Zivadinov R. Risk factors for and management of cognitive dysfunction in multiple sclerosis. Nat Rev Neurol. 2011;7(6):332-342. doi: 10.1038/NRNEUROL.2011.61.

Kalb R, Beier M, Benedict RHB, Charvet L, Costello K, Feinstein A, et al. Recommendations for cognitive screening and management in multiple sclerosis care. Mult Scler. 2018;24(13):1665-1680. doi: 10.1177/1352458518803785.

Erdfelder E, Faul F, Buchner A, Lang AG. Statistical power analyses using G*Power 3.1: Tests for correlation and regression analyses. Behav Res Methods. 2009;41(4):1149-1160. doi: 10.3758/BRM.41.4.1149.

Expanded Disability Status Scale (EDSS) | MS Trust [Internet]. [cited 2026 Feb 3]. Available from: https://mstrust.org.uk/a-z/expanded-disability-status-scale-edss

Roesel I, Froehlich D, Joos S, Valentini J, Mauch H, Martus P. The patient activation measure-13 (PAM-13) in an oncology patient population: psychometric properties and dimensionality evaluation. Health Qual Life Outcomes. 2024;22(1). doi: 10.1186/s12955-024-02255-w.

Benedict RHB, Amato MP, DeLuca J, Geurts JJG. Cognitive impairment in multiple sclerosis: clinical management, MRI, and therapeutic avenues. Lancet Neurol. 2020;19(10):860. doi: 10.1016/S1474-4422(20)30277-5.

Filippi M, Brück W, Chard D, Fazekas F, Geurts JJG, Enzinger C, et al. Association between pathological and MRI findings in multiple sclerosis. Lancet Neurol. 2019;18(2):198-210. doi: 10.1016/S1474-4422(18)30451-4.

Downloads

Published

2026-05-03

How to Cite

Mohammed, A. M., Mohammed, S. I., & Al-Johar, Z. A.-G. (2026). Predictors of Patient Activation among Individuals with Multiple Sclerosis: Evidence from a Cross-Sectional Study. Al-Rafidain Journal of Medical Sciences ( ISSN 2789-3219 ), 10(2), 202–209. https://doi.org/10.54133/ajms.v10i2.2901

Issue

Section

Original article

Most read articles by the same author(s)

1 2 > >> 

Similar Articles

<< < 12 13 14 15 16 17 18 19 20 21 > >> 

You may also start an advanced similarity search for this article.